So far so good this morning, so it seems it's not viewed as a negative. Mind you, markets just opened so there is an entire day left. Let's see how the day unfolds...
I don't think they can sell shares until July 14 or until the share price is $3.50. PTSD data will be out by then and hopefully it's positive to drive the price up followed by positive Fibro. My fingers are crossed real hard.
I really wish I got paid a nickel for every post that brings up shorts roasting. I'd be retired by now.
Corporate updates are always just corporate updates. They'll probably show the most recent presentation that you can view on their website and talk a bit about the upcoming PIII STS. Don't expect much.
Just put them all on ignore and you'll feel better. It cleans the board up nicely.
Don't quote me but from what I remember reading over the last little bit, but I haven't seen anyone with more than 40% confidence in the PTSD study.
Ok, moron. Back on ignore you go.
They keep claiming it's a neutral article and that it started as research into the science but turned into researching management, specifically Cheryl Cohen.
Makes you question the intent of the article if they're indeed writing about something that's already been beaten to death.
I agree, I'm fully expecting it to be a hit article. Someone is in dialogue with them about it. The author is saying they were bullish, then bearish, but now neutral. Sounds super fishy to me.
Some person on Stocktwits has stated that an article has been submitted, which is where I'm getting my info from. He claims it's a neutral article that neither says buy or sell, but he claims it's interesting. He says it's more of an investigation into their Board and Management.
Just google: Smarter Analyst H.C. Wainwright Pounds The Table On CytRx Corporation (CYTR)
You should be able to see it.